The findings of this study confirmed that OSR1 is broadly underexpressed across multiple tumor types, including breast cancer, bladder urothelial carcinoma, lung adenocarcinoma, and lung squamous cell carcinoma, while elevated expression is observed in select cancers such as clear cell and papillary renal cell carcinomas. Here, OSR1 is linked to lung adenocarcinoma.